Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Raw Materials (2019 - 2025)

Historic Raw Materials for INVO Fertility (IVF) over the last 7 years, with Q3 2025 value amounting to $53614.0.

  • INVO Fertility's Raw Materials rose 14.38% to $53614.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $53614.0, marking a year-over-year increase of 14.38%. This contributed to the annual value of $53537.0 for FY2024, which is 10.85% up from last year.
  • Latest data reveals that INVO Fertility reported Raw Materials of $53614.0 as of Q3 2025, which was up 14.38% from $51501.0 recorded in Q2 2025.
  • In the past 5 years, INVO Fertility's Raw Materials registered a high of $77909.0 during Q1 2022, and its lowest value of $51501.0 during Q2 2025.
  • Moreover, its 5-year median value for Raw Materials was $62440.0 (2023), whereas its average is $61552.7.
  • In the last 5 years, INVO Fertility's Raw Materials crashed by 3909.18% in 2021 and then surged by 1468.0% in 2022.
  • Quarter analysis of 5 years shows INVO Fertility's Raw Materials stood at $67605.0 in 2021, then rose by 1.65% to $68723.0 in 2022, then decreased by 22.18% to $53479.0 in 2023, then grew by 0.11% to $53537.0 in 2024, then grew by 0.14% to $53614.0 in 2025.
  • Its Raw Materials stands at $53614.0 for Q3 2025, versus $51501.0 for Q2 2025 and $52660.0 for Q1 2025.